GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19 Vaccine
Japan’s Shionogi to Provide 120 Million Doses of COVID-19 Vaccines Annually
2021-07-08
COVID-19 Delta Variant
Korea Receives 700,000 COVID-19 Vaccines from Israel Under a Swap Deal
2021-07-06
M&A Healthcare
EQT Private Equity and Goldman Sachs Spend $8.5 Billion to Acquire Parexel
2021-07-04
COVID-19 Monoclonal Antibody
GSK, Vir Ink Deal with Government of Singapore to Supply COVID-19 Drug Sotrovimab
2021-07-03
Trials & Approvals Vaccine
Bharat Biotech’s Covaxin On its Way Towards WHO Approval
2021-07-03
COVID-19 Vaccine
Korea to Begin Production of Sputnik Light COVID-19 Vaccine in September
2021-06-29
COVID-19
Outlining the Future of Vaccine Business: Industry, Investment, and Public Health
2021-06-21
COVID-19
Breaking Barriers in COVID-19 Vaccine Production: A Discussion with Pfizer CEO Albert Bourla
2021-06-18
Healthcare
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
COVID-19 mRNA Vaccine
South Korea Seeks Global Partners for Upping COVID-19 Vaccine Production
2021-06-18
COVID-19 Monoclonal Antibody
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
IPO
Is the Path to Public Market Smooth? A Candid Discussion on SPACs
2021-06-15
COVID-19 Vaccine
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
COVID-19 Delta Variant
COVID-19: Rise in UK Cases Trigger Global Concerns Over “Highly Infectious” Delta Variant
2021-06-14
Singapore and Australia’s Prime Ministers Discuss Initiation of Air Travel Bubble
2021-06-13
1 … 34 35 36 37 38 … 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top